Comparative effectiveness and safety of biologics and targeted small-molecule therapies plus stable background therapy in systemic lupus erythematosus: a systematic review and network meta-analysis

By
Wenjuan Li
Yanhong Zhao
Siyan Shu
Ran Li
Yu Huang
Yuanyuan Gong
Guanhua Zhao
Yuxin Fan
Jianchang He
May 1, 2026
0 min

Frontiers In Immunology

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

The Johns Hopkins Hospital / Johns Hopkins University School of Medicine

Baltimore, Maryland
Key Differentiators
- Rheumatology
#2

Cleveland Clinic

Cleveland, Ohio
Key Differentiators
- Rheumatology

Original Source(s)

Frontiers In Immunology

Comparative effectiveness and safety of biologics and targeted small-molecule therapies plus stable background therapy in systemic lupus erythematosus: a systematic review and network meta-analysis

by Wenjuan Li, Yanhong Zhao, Siyan Shu, Ran Li, Yu Huang, Yuanyuan Gong, Guanhua Zhao, Yuxin Fan, Jianchang He
May 1, 2026

Related Content

Roswell Park Comprehensive Cancer Center

Roswell Park Offering CAR T Trial for Autoimmune Conditions

While most CAR T-cell therapies and clinical trials are directed at cancers, a new phase 1 trial at Roswell Park Comprehensive Cancer Center is open and recruiting patients with a variety of autoimmune conditions.